Glaxosmithkline Share News (GSK)

UPDATE 3-Sanofi plans to reshape via $20 bln asset swap with Boehringer

* Sanofi in talks to acquire Boehringer consumer health * Boehringer to buy Sanofi's animal health arm Merial * Planned deal shows drive by new CEO to simplify Sanofi * Sanofi shares jump more than 4 percent (Adds banks advising Boehringer, Boehringer comment on financing, upd

Amgen reacquires rights to three drugs from Glaxo in 48 countries

Dec 14 (Reuters) - Amgen Inc on Monday said it had reached a deal with British drugmaker GlaxoSmithKline to reacquire the sales rights to three of its products in 48 countries, including Australia as well as markets in Asia, South America and Europe. The three Amgen drugs are the osteoporos

BUZZ-GlaxoSmithKline: new lung drugs starting to gain momentum

** GlaxoSmithKline's new inhaled lung drugs finally building momentum in all-important U.S. market, with Breo weekly prescriptions hitting 30,000 and Anoro/Incruse also improving, according to IMS data ** GSK insiders say more focused approach by U.S. sales force helping, after earlier disa

UPDATE 1-U.S. FDA advisers recommend approval of Teva asthma drug for adults

(Adds background) Dec 9 (Reuters) - An advisory committee to the U.S. Food and Drug Administration recommended on Wednesday that the agency approve Teva Pharmaceutical Industries Ltd's Read more

BROKER RATINGS SUMMARY: Merrill Lynch Raises Glaxo To Buy From Neutral

BROKER RATINGS SUMMARY: Nomura Cuts Kingfisher To Reduce From Neutral

ReNeuron Group Appoints Ex-Glaxo Executive Owen To Board

GlaxoSmithKline Gets European Marketing Authorisation For Nucala

GSK Says Nucala Available In US For Sub-group Of Patients With Severe Asthma

Broker tips: IAG, BHP Billiton, AstraZeneca, GSK

(ShareCast News) - Clear skies lie ahead for the European Airlines sector going into the winter trading period, thanks to a favourable outlook for capacity growth and given the considerable fall in oil prices since August 2015, Nomura said. The global macroeconomic outlook, notably in the core UK an

WINNERS & LOSERS SUMMARY: Greene King Stock In Good Spirits

AstraZeneca rallies on double upgrade from Morgan Stanley

(ShareCast News) - Pharmaceutical stocks got a boost on Wednesday as Morgan Stanley double upgraded AstraZeneca to 'overweight' from 'underweight' and said it was among its top picks. The bank, which lifted AZN's target price to 5,300p from 4,300p, said it has underperformed dramatically over the pa

BROKER RATINGS SUMMARY: JPMorgan, UBS And Barclays Like Ibstock

LONDON MARKET OPEN: Pharma Stocks Lead Gains; Sage Group Shares Down

RPT-Beijing aims to refill medicine chest with "Made in China" drugs

(Repeats Sunday story with no changes) * Local drugs intensify competition as China squeezes prices * Raised quality bar threatens "branded generics" cash cow * China R&D on long road to developing new innovative drugs By Ben Hirschler and Adam Jourdan SHANGHAI, Nov